
Loading, please wait...

Loading, please wait...

Additionally, clinicians often struggle because they must identify all potential risk factors for cardiovascular disease. Although age and weight are standard metrics, consequently, a woman's reproductive history also provides critical clinical clues. Therefore, a recent population-based cohort study explored the connection between eGFR and hypertension risk in women. Specifically, the research focused on those with a history of adverse pregnancy outcomes (APOs), such as preeclampsia or gestational diabetes. Because the study utilized data from the Tehran Lipid and Glucose Study (TLGS), thus involving 2,404 participants, researchers consequently tracked annual changes in kidney function over several years. Notably, they found that women with a history of APOs similarly showed significant kidney alterations. However, these shifts subsequently influenced their long-term blood pressure status.
For instance, in women with previous complications, the trajectory of kidney function moreover acts as a powerful predictor of health. Specifically, a one z-score positive change in eGFR and hypertension risk was consequently associated with an 18.4% reduction in the incidence of high blood pressure. In contrast, this protective association however was entirely absent in women who had uncomplicated pregnancies. Thus, the metabolic stress test of pregnancy consequently unmasks underlying renal and vascular vulnerabilities that persist for decades. As a result, doctors therefore should monitor kidney function regularly in patients with a history of APOs. Furthermore, maintaining or improving eGFR levels similarly serves as a protective buffer against cardiovascular decline. Moreover, these findings accordingly show that obstetric history subsequently remains a lifelong internal medicine priority. Therefore, clinicians consequently must integrate pregnancy data into routine primary care immediately to improve outcomes.
A history of APOs, such as preeclampsia, acts as a stress test for the body, often indicating an underlying predisposition to cardiovascular and renal issues. In the long term, these women face a higher risk for both chronic kidney disease and hypertension compared to those with healthy pregnancies.
Yes, research indicates that maintaining or improving eGFR and hypertension risk profiles is possible. In women with prior pregnancy complications, positive shifts in eGFR are independently linked to a lower incidence of high blood pressure, highlighting the importance of renal health in cardiovascular prevention.
Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Saei Ghare Naz M et al. Adverse pregnancy outcomes, longitudinal change in eGFR, and incident hypertension in women: a population-based cohort study. Ren Fail. 2026 Dec undefined. doi: 10.1080/0886022X.2026.2644784. PMID: 42056731.
2. Crump C et al. Adverse pregnancy outcomes and long-term risk of chronic kidney disease in women: national cohort and co-sibling study. BMJ. 2024;384:e075675. doi: 10.1136/bmj-2023-075675.
3. Ku E et al. Change in Measured GFR Versus eGFR and CKD Outcomes. J Am Soc Nephrol. 2016 Jul;27(7):2196-204. doi: 10.1681/ASN.2015090981.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Study reveals that positive eGFR changes significantly reduce hypertension risk in women with prior adverse pregnancy outcomes, emphasizing renal monitoring...
4 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today